DFB Pharmaceuticals
Practical innovations for life
banenr-paclitaxel.jpg

NanOlogy

Big ideas in action.

 

Clinical Development of a Naked Submicron Particle Platform


nanology dfb1.png
 

DFB formed NanOlogy in 2015 to transform systemic chemotherapy into local delivery to treat cancer and other serious illnesses.

NanOlogy LLC is a company formed by the collaboration of DFB Pharmaceuticals LLC, CritiTech, Inc. of Lawrence, KS, and US Biotest Inc. of San Luis Obispo, CA, to finance and develop a breakthrough submicron particle production technology platform aimed at transforming systemic chemotherapy into local delivery - directly to the site of disease - to improve the lives of patients with cancer and other serious illnesses.

visit the Nanology website >

see our clinical drug development pipeline >